Published in the Journal of Medicinal Chemistry, the study shows that the new molecule—called POM-L-BHDU—can effectively ...

Bryan Walsh is a senior editorial ... effects of the shingles vaccine, other studies of the vaccine have come to similar conclusions. Beyond the promise of preventive treatment, the new study ...

Senior researcher Professor Karla Helbig ... GS-1 has now entered clinical trials to develop a topical treatment for shingles patients. Wintermute Biomedical Chief Scientific Officer Dr. Alyce ...

Shingles, for instance, is a painful and incapacitating condition resulting from the reactivation of the chickenpox virus – and is very common in seniors. The risk of developing this condition ...

If successful, POM-L-BHDU could be a game changer for the millions of people affected by herpes and shingles around the world ...